198 related articles for article (PubMed ID: 24715498)
1. Development of a realistic in vivo bone metastasis model of human renal cell carcinoma.
Valta MP; Zhao H; Ingels A; Thong AE; Nolley R; Saar M; Peehl DM
Clin Exp Metastasis; 2014 Jun; 31(5):573-84. PubMed ID: 24715498
[TBL] [Abstract][Full Text] [Related]
2. Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal cell carcinoma tumorgrafts.
Ingels A; Zhao H; Thong AE; Saar M; Valta MP; Nolley R; Santos J; Peehl DM
Int J Cancer; 2014 May; 134(10):2322-9. PubMed ID: 24243565
[TBL] [Abstract][Full Text] [Related]
3. Tissue slice grafts of human renal cell carcinoma: an authentic preclinical model with high engraftment rate and metastatic potential.
Thong AE; Zhao H; Ingels A; Valta MP; Nolley R; Santos J; Young SR; Peehl DM
Urol Oncol; 2014 Jan; 32(1):43.e23-30. PubMed ID: 23911681
[TBL] [Abstract][Full Text] [Related]
4. BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.
Pan T; Lin SC; Yu KJ; Yu G; Song JH; Lewis VO; Bird JE; Moon B; Lin PP; Tannir NM; Jonasch E; Wood CG; Gallick GE; Yu-Lee LY; Lin SH; Satcher RL
Neoplasia; 2018 Jan; 20(1):32-43. PubMed ID: 29190493
[TBL] [Abstract][Full Text] [Related]
5. Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation.
Zhao H; Nolley R; Chan AMW; Rankin EB; Peehl DM
Cancer Biol Ther; 2017 Nov; 18(11):863-871. PubMed ID: 27715452
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
Kominsky SL; Doucet M; Brady K; Weber KL
J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a new renal cell carcinoma bone metastasis mouse model.
Strube A; Stepina E; Mumberg D; Scholz A; Hauff P; Käkönen SM
Clin Exp Metastasis; 2010 May; 27(5):319-30. PubMed ID: 20443133
[TBL] [Abstract][Full Text] [Related]
8. Unique angiogenic and vasculogenic properties of renal cell carcinoma in a xenograft model of bone metastasis are associated with high levels of vegf-a and decreased ang-1 expression.
Xie C; Schwarz EM; Sampson ER; Dhillon RS; Li D; O'Keefe RJ; Tyler W
J Orthop Res; 2012 Feb; 30(2):325-33. PubMed ID: 21809376
[TBL] [Abstract][Full Text] [Related]
9. Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma.
Wang J; You H; Qi J; Yang C; Ren Y; Cheng H
Oncotarget; 2017 Mar; 8(10):17012-17026. PubMed ID: 28199984
[TBL] [Abstract][Full Text] [Related]
10. Effect of host immunity on metastatic potential in renal cell carcinoma: the assessment of optimal in vivo models to study metastatic behavior of renal cancer cells.
Kobayashi M; Morita T; Chun NA; Matsui A; Takahashi M; Murakami T
Tumour Biol; 2012 Apr; 33(2):551-9. PubMed ID: 22219032
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional (3D) culture of bone-derived human 786-O renal cell carcinoma retains relevant clinical characteristics of bone metastases.
Pan T; Fong EL; Martinez M; Harrington DA; Lin SH; Farach-Carson MC; Satcher RL
Cancer Lett; 2015 Aug; 365(1):89-95. PubMed ID: 26004343
[TBL] [Abstract][Full Text] [Related]
12. A bone-seeking clone exhibits different biological properties from the ACHN parental human renal cell carcinoma in vivo and in vitro.
Wang J; Chen A; Yang C; Zeng H; Qi J; Guo FJ
Oncol Rep; 2012 Apr; 27(4):1104-10. PubMed ID: 22139406
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast function.
Maita S; Yuasa T; Tsuchiya N; Mitobe Y; Narita S; Horikawa Y; Hatake K; Fukui I; Kimura S; Maekawa T; Habuchi T
Int J Cancer; 2012 Feb; 130(3):677-84. PubMed ID: 21387300
[TBL] [Abstract][Full Text] [Related]
14. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
[TBL] [Abstract][Full Text] [Related]
15. Cadherin-11 in renal cell carcinoma bone metastasis.
Satcher RL; Pan T; Cheng CJ; Lee YC; Lin SC; Yu G; Li X; Hoang AG; Tamboli P; Jonasch E; Gallick GE; Lin SH
PLoS One; 2014; 9(2):e89880. PubMed ID: 24587095
[TBL] [Abstract][Full Text] [Related]
16. Eight proteins play critical roles in RCC with bone metastasis via mitochondrial dysfunction.
Wang J; Zhao X; Qi J; Yang C; Cheng H; Ren Y; Huang L
Clin Exp Metastasis; 2015 Aug; 32(6):605-22. PubMed ID: 26115722
[TBL] [Abstract][Full Text] [Related]
17. Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples.
Dong Y; Manley BJ; Becerra MF; Redzematovic A; Casuscelli J; Tennenbaum DM; Reznik E; Han S; Benfante N; Chen YB; Arcila ME; Aras O; Voss MH; Feldman DR; Motzer RJ; Fabbri N; Healey JH; Boland PJ; Chawla M; Durack JC; Lee CH; Coleman JA; Russo P; Hakimi AA; Cheng EH; Hsieh JJ
Eur Urol Focus; 2017 Dec; 3(6):590-598. PubMed ID: 28753786
[TBL] [Abstract][Full Text] [Related]
18. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
20. Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model.
Hillman GG; Wang Y; Che M; Raffoul JJ; Yudelev M; Kucuk O; Sarkar FH
BMC Cancer; 2007 Jan; 7():4. PubMed ID: 17212824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
